NTSR1 and neoplasm: Similarly, in the invasive component of 106 samples of IDC studied by Dupouy et al., the majority showed a high proportion of NTR1-positive cells (from 50 to 100%) using immunohistochemistry, and even 38 patients (35%) exhibited very high NTR1 expression (≥80% of tumor cells).